Anna Marrs Sells 363 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCUGet Free Report) Director Anna Marrs sold 363 shares of the firm’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $46.33, for a total transaction of $16,817.79. Following the sale, the director directly owned 12,251 shares in the company, valued at approximately $567,588.83. The trade was a 2.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Anna Marrs also recently made the following trade(s):

  • On Friday, December 5th, Anna Marrs sold 363 shares of Docusign stock. The shares were sold at an average price of $64.50, for a total transaction of $23,413.50.

Docusign Trading Up 4.3%

Shares of Docusign stock traded up $2.01 on Thursday, hitting $48.23. The stock had a trading volume of 4,751,965 shares, compared to its average volume of 4,920,508. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of 33.73, a P/E/G ratio of 2.03 and a beta of 1.03. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $94.67. The company’s 50 day moving average price is $54.26 and its 200 day moving average price is $66.00.

Hedge Funds Weigh In On Docusign

Several hedge funds and other institutional investors have recently made changes to their positions in DOCU. Central Pacific Bank Trust Division acquired a new stake in Docusign in the fourth quarter valued at approximately $25,000. Modus Advisors LLC purchased a new position in shares of Docusign in the fourth quarter valued at $27,000. Torren Management LLC purchased a new position in shares of Docusign in the fourth quarter valued at $28,000. Aventura Private Wealth LLC acquired a new stake in Docusign during the 4th quarter valued at $30,000. Finally, True Wealth Design LLC increased its stake in Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after buying an additional 222 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on DOCU shares. Piper Sandler lowered their price target on Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a report on Wednesday, December 17th. BTIG Research cut their price target on Docusign from $88.00 to $70.00 and set a “buy” rating for the company in a report on Wednesday, February 18th. Wedbush decreased their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Docusign in a research note on Monday. Five analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $78.80.

View Our Latest Analysis on DOCU

Docusign Company Profile

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.